LOCAL biopharmaceutical company Bone Medical has announced that it will employ the Bank of New York for an American Depository Receipt program in the US.
The establishment of the ADR program will enable the purchase of Bone shares by American investors.
The arrangement will include the promotion of Bone to US investors.
Bone is a supplier of drugs for osteoporosis and arthritis patients.
The Bank of New York is the world’s largest depository for American and global depository receipts, allowing non-US companies to offer US dollar-denominated securities to investors worldwide.